share_log

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

艾伯維公司 | 25-NSE:由交易所申報的註銷已到期、已贖回、已兌付證券的通知
美股sec公告 ·  06/03 11:31
Moomoo AI 已提取核心訊息
The New York Stock Exchange (NYSE) has notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of Biora Therapeutics, Inc. This action is set to take place at the start of business on June 14, 2024, in accordance with Rule 12d2-2(a). The securities in question were fully redeemed, paid at maturity, or retired on June 3, 2024, which led to their suspension from trading on the same day. The notice of effectiveness for this action was filed with the SEC and is set to become effective on May 31, 2024, at 4:00 P.M.
The New York Stock Exchange (NYSE) has notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of Biora Therapeutics, Inc. This action is set to take place at the start of business on June 14, 2024, in accordance with Rule 12d2-2(a). The securities in question were fully redeemed, paid at maturity, or retired on June 3, 2024, which led to their suspension from trading on the same day. The notice of effectiveness for this action was filed with the SEC and is set to become effective on May 31, 2024, at 4:00 P.M.
紐交所已通知證券交易委員會 (SEC) 有關拆除 Biora Therapeutics 全部證券等級的意向。根據條例12d2-2(a),此舉將於2024年6月14日營業開始時生效。有關證券已經在2024年6月3日全部贖回、到期支付或退休,因此當天暫停交易。此舉的生效通知已向SEC提交,預定於2024年5月31日下午4:00生效。
紐交所已通知證券交易委員會 (SEC) 有關拆除 Biora Therapeutics 全部證券等級的意向。根據條例12d2-2(a),此舉將於2024年6月14日營業開始時生效。有關證券已經在2024年6月3日全部贖回、到期支付或退休,因此當天暫停交易。此舉的生效通知已向SEC提交,預定於2024年5月31日下午4:00生效。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息